Skip to main content

ORIGINAL RESEARCH article

Front. Endocrinol.
Sec. Reproduction
Volume 15 - 2024 | doi: 10.3389/fendo.2024.1431200
This article is part of the Research Topic A Lifecourse Perspective on Polycystic Ovary Syndrome (PCOS): Bridging Gaps in Research and Practice View all 8 articles

Unveiling the Molecular Landscape of PCOS: Identifying Hub Genes and Causal Relationships through Bioinformatics and Mendelian Randomization

Provisionally accepted
Yifang He Yifang He Yanli Wang Yanli Wang Xiali Wang Xiali Wang Shuangping Deng Shuangping Deng Dandan Wang Dandan Wang Qingqing Huang Qingqing Huang Guorong Lyu Guorong Lyu *
  • The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China

The final, formatted version of the article will be published soon.

    Background: Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with various contributing factors. Understanding the molecular mechanisms underlying PCOS is essential for developing effective treatments. This study aimed to identify hub genes and investigate potential molecular mechanisms associated with PCOS through a combination of bioinformatics analysis and Mendelian randomization (MR).Methods: This study employed bioinformatics analysis in conjunction with MR methods using publicly available databases to identify hub genes. We employed complementary MR methods, including inverse-variance weighted (IVW), to determine the causal causal relationship between the hub genes and PCOS. Sensitivity analyses were performed to ensure results reliability. Enrichment analysis and immune infiltration analysis were further conducted to assess the role and mechanisms of hub genes in the development of PCOS. Additionally, we validated hub gene expression in both an animal model and serum samples from PCOS patients using qRT-PCR. Results: IVW analysis revealed significant associations between 10 hub genes and the risk of PCOS: CD93 (P= 0.004; OR 95%CI= 1.150 (1.046, 1.264)), CYBB (P= 0.013; OR 95%CI= 1.650 (1.113,2.447)), DOCK8 (P= 0.048; OR 95%CI= 1.223 (1.002,1.494)), IRF1 (P= 0.036; OR 95%CI= 1.343 (1.020,1.769)), MBOAT1 (P= 0.033; OR 95%CI= 1.140 (1.011,1.285)), MYO1F (P= 0.012; OR 95%CI= 1.325 (1.065,1.649)), NLRP1 (P= 0.020; OR 95%CI= 1.143 (1.021,1.280)), NOD2 (P= 0.002; OR 95%CI= 1.139 (1.049,1.237)), PIK3R1 (P= 0.040; OR 95%CI= 1.241 (1.010,1.526)), PTER (P= 0.015; OR 95%CI= 0.923 (0.866,0.984)). No heterogeneity and pleiotropy were observed. Hub genes mainly enriched in positive regulation of cytokine production and TNF signaling pathway, and exhibited positive or negative correlations with different immune cells in individuals with PCOS. qRT-PCR 3 validation in both the rat model and patient serum samples confirmed hub gene expression trends consistent with our combined analysis results. Conclusions: Our bioinformatics combined with MR analysis revealed that CD93, CYBB, DOCK8, IRF1, MBOAT1, MYO1F, NLRP1, NOD2, PIK3R1 increase the risk of PCOS, while PTER decreases the risk of PCOS. This discovery has implications for clinical decision-making in terms of disease diagnosis, prognosis, treatment strategies, and opens up novel avenues for drug development.

    Keywords: pcos, Bioinformatic analysis, Mendelian randomization, causal relationship, SNP

    Received: 11 May 2024; Accepted: 20 Nov 2024.

    Copyright: © 2024 He, Wang, Wang, Deng, Wang, Huang and Lyu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Guorong Lyu, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.